In the following sub-sections we will discuss how these transcription factors, in collaboration with other signalling pathways, benefit cHL and ALK+ ALCL by promoting proliferation/growth, suppressing apoptosis, and evading the host immune response (Fig. 2). This evidence concerns the gene ALK and anaplastic large cell lymphoma.